nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—CYP1A2—chronic obstructive pulmonary disease	0.232	0.542	CbGaD
Pimozide—HTR2A—chronic obstructive pulmonary disease	0.196	0.458	CbGaD
Pimozide—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.0565	0.161	CbGbCtD
Pimozide—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0412	0.117	CbGbCtD
Pimozide—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0304	0.0864	CbGbCtD
Pimozide—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0304	0.0864	CbGbCtD
Pimozide—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0238	0.0678	CbGbCtD
Pimozide—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0231	0.0657	CbGbCtD
Pimozide—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0231	0.0657	CbGbCtD
Pimozide—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0206	0.0585	CbGbCtD
Pimozide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0194	0.0551	CbGbCtD
Pimozide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0131	0.0372	CbGbCtD
Pimozide—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0128	0.0363	CbGbCtD
Pimozide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0125	0.0355	CbGbCtD
Pimozide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0111	0.0316	CbGbCtD
Pimozide—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0109	0.031	CbGbCtD
Pimozide—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0103	0.0293	CbGbCtD
Pimozide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00653	0.0186	CbGbCtD
Pimozide—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00626	0.263	CbGeAlD
Pimozide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00617	0.0175	CbGbCtD
Pimozide—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.00227	0.0955	CbGeAlD
Pimozide—Droperidol—HTR2A—chronic obstructive pulmonary disease	0.000724	0.19	CrCbGaD
Pimozide—CALM3—bronchus—chronic obstructive pulmonary disease	0.000661	0.0278	CbGeAlD
Pimozide—CALM3—smooth muscle tissue—chronic obstructive pulmonary disease	0.000647	0.0272	CbGeAlD
Pimozide—CALM2—respiratory system—chronic obstructive pulmonary disease	0.000631	0.0265	CbGeAlD
Pimozide—CALM1—respiratory system—chronic obstructive pulmonary disease	0.000628	0.0264	CbGeAlD
Pimozide—Sertindole—SLC6A4—chronic obstructive pulmonary disease	0.000607	0.159	CrCbGaD
Pimozide—CALM3—trachea—chronic obstructive pulmonary disease	0.000594	0.0249	CbGeAlD
Pimozide—DRD2—respiratory system—chronic obstructive pulmonary disease	0.00058	0.0244	CbGeAlD
Pimozide—CALM2—connective tissue—chronic obstructive pulmonary disease	0.000555	0.0233	CbGeAlD
Pimozide—CALM1—connective tissue—chronic obstructive pulmonary disease	0.000553	0.0232	CbGeAlD
Pimozide—CALM2—bronchus—chronic obstructive pulmonary disease	0.000519	0.0218	CbGeAlD
Pimozide—CALM1—bronchus—chronic obstructive pulmonary disease	0.000517	0.0217	CbGeAlD
Pimozide—CALM2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000508	0.0213	CbGeAlD
Pimozide—CALM1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000506	0.0212	CbGeAlD
Pimozide—Fluspirilene—SLC6A4—chronic obstructive pulmonary disease	0.000495	0.13	CrCbGaD
Pimozide—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000489	0.0205	CbGeAlD
Pimozide—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000489	0.00469	CcSEcCtD
Pimozide—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.000487	0.00467	CcSEcCtD
Pimozide—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000485	0.00466	CcSEcCtD
Pimozide—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000481	0.00461	CcSEcCtD
Pimozide—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.00048	0.0046	CcSEcCtD
Pimozide—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.000472	0.0198	CbGeAlD
Pimozide—Sertindole—HTR2A—chronic obstructive pulmonary disease	0.000466	0.122	CrCbGaD
Pimozide—CALM2—trachea—chronic obstructive pulmonary disease	0.000466	0.0196	CbGeAlD
Pimozide—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.000465	0.00446	CcSEcCtD
Pimozide—CALM1—trachea—chronic obstructive pulmonary disease	0.000464	0.0195	CbGeAlD
Pimozide—HRH1—respiratory system—chronic obstructive pulmonary disease	0.000458	0.0192	CbGeAlD
Pimozide—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000447	0.00428	CcSEcCtD
Pimozide—CYP2E1—respiratory system—chronic obstructive pulmonary disease	0.00044	0.0185	CbGeAlD
Pimozide—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000438	0.0042	CcSEcCtD
Pimozide—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.000436	0.00418	CcSEcCtD
Pimozide—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.00043	0.00413	CcSEcCtD
Pimozide—CALM3—lung—chronic obstructive pulmonary disease	0.000426	0.0179	CbGeAlD
Pimozide—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000422	0.00405	CcSEcCtD
Pimozide—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000422	0.00405	CcSEcCtD
Pimozide—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000408	0.00392	CcSEcCtD
Pimozide—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000406	0.00389	CcSEcCtD
Pimozide—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.000405	0.00388	CcSEcCtD
Pimozide—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000403	0.00387	CcSEcCtD
Pimozide—Domperidone—CYP1A2—chronic obstructive pulmonary disease	0.000403	0.106	CrCbGaD
Pimozide—HRH1—connective tissue—chronic obstructive pulmonary disease	0.000403	0.0169	CbGeAlD
Pimozide—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000398	0.00382	CcSEcCtD
Pimozide—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.000395	0.00379	CcSEcCtD
Pimozide—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.000395	0.00379	CcSEcCtD
Pimozide—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.000388	0.00373	CcSEcCtD
Pimozide—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.000387	0.00371	CcSEcCtD
Pimozide—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.000387	0.00371	CcSEcCtD
Pimozide—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.000387	0.00371	CcSEcCtD
Pimozide—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000385	0.00369	CcSEcCtD
Pimozide—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000383	0.00367	CcSEcCtD
Pimozide—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000382	0.0161	CbGeAlD
Pimozide—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000381	0.00365	CcSEcCtD
Pimozide—Fluspirilene—HTR2A—chronic obstructive pulmonary disease	0.00038	0.0996	CrCbGaD
Pimozide—Endocrine disorder—Prednisone—chronic obstructive pulmonary disease	0.00038	0.00364	CcSEcCtD
Pimozide—Flunarizine—CYP1A1—chronic obstructive pulmonary disease	0.000379	0.0992	CrCbGaD
Pimozide—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000374	0.00359	CcSEcCtD
Pimozide—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.000373	0.00358	CcSEcCtD
Pimozide—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000373	0.00358	CcSEcCtD
Pimozide—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000373	0.00357	CcSEcCtD
Pimozide—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000372	0.00357	CcSEcCtD
Pimozide—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000369	0.00354	CcSEcCtD
Pimozide—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000369	0.00354	CcSEcCtD
Pimozide—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000369	0.00354	CcSEcCtD
Pimozide—HRH1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000369	0.0155	CbGeAlD
Pimozide—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000368	0.00353	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000366	0.00351	CcSEcCtD
Pimozide—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000366	0.00351	CcSEcCtD
Pimozide—Flunarizine—CYP1A2—chronic obstructive pulmonary disease	0.000365	0.0956	CrCbGaD
Pimozide—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000365	0.0035	CcSEcCtD
Pimozide—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000361	0.00346	CcSEcCtD
Pimozide—Amenorrhoea—Prednisone—chronic obstructive pulmonary disease	0.000358	0.00344	CcSEcCtD
Pimozide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000357	0.00343	CcSEcCtD
Pimozide—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000357	0.00343	CcSEcCtD
Pimozide—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000354	0.0034	CcSEcCtD
Pimozide—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000354	0.0034	CcSEcCtD
Pimozide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000352	0.00338	CcSEcCtD
Pimozide—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000352	0.00338	CcSEcCtD
Pimozide—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000352	0.00338	CcSEcCtD
Pimozide—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000352	0.00338	CcSEcCtD
Pimozide—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00035	0.00336	CcSEcCtD
Pimozide—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000348	0.00334	CcSEcCtD
Pimozide—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000347	0.00333	CcSEcCtD
Pimozide—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000345	0.00331	CcSEcCtD
Pimozide—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000345	0.00331	CcSEcCtD
Pimozide—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000343	0.00329	CcSEcCtD
Pimozide—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000339	0.00325	CcSEcCtD
Pimozide—HRH1—trachea—chronic obstructive pulmonary disease	0.000338	0.0142	CbGeAlD
Pimozide—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000337	0.0141	CbGeAlD
Pimozide—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000336	0.00322	CcSEcCtD
Pimozide—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000336	0.00322	CcSEcCtD
Pimozide—CALM2—lung—chronic obstructive pulmonary disease	0.000335	0.0141	CbGeAlD
Pimozide—Increased appetite—Prednisolone—chronic obstructive pulmonary disease	0.000335	0.00321	CcSEcCtD
Pimozide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000334	0.0032	CcSEcCtD
Pimozide—CALM1—lung—chronic obstructive pulmonary disease	0.000333	0.014	CbGeAlD
Pimozide—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000332	0.00319	CcSEcCtD
Pimozide—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000332	0.00318	CcSEcCtD
Pimozide—Cataract—Prednisone—chronic obstructive pulmonary disease	0.000331	0.00317	CcSEcCtD
Pimozide—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000329	0.00316	CcSEcCtD
Pimozide—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000328	0.00314	CcSEcCtD
Pimozide—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000328	0.00314	CcSEcCtD
Pimozide—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000326	0.00313	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000322	0.00309	CcSEcCtD
Pimozide—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000321	0.00308	CcSEcCtD
Pimozide—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000321	0.00308	CcSEcCtD
Pimozide—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000321	0.00308	CcSEcCtD
Pimozide—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00032	0.00307	CcSEcCtD
Pimozide—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000317	0.00304	CcSEcCtD
Pimozide—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000315	0.00302	CcSEcCtD
Pimozide—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000309	0.00297	CcSEcCtD
Pimozide—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000309	0.00296	CcSEcCtD
Pimozide—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000309	0.00296	CcSEcCtD
Pimozide—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000308	0.0129	CbGeAlD
Pimozide—DRD2—lung—chronic obstructive pulmonary disease	0.000308	0.0129	CbGeAlD
Pimozide—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000305	0.00293	CcSEcCtD
Pimozide—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.00291	CcSEcCtD
Pimozide—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000303	0.0029	CcSEcCtD
Pimozide—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000302	0.0029	CcSEcCtD
Pimozide—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000302	0.0029	CcSEcCtD
Pimozide—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000302	0.0029	CcSEcCtD
Pimozide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000298	0.00286	CcSEcCtD
Pimozide—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000298	0.00286	CcSEcCtD
Pimozide—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.00286	CcSEcCtD
Pimozide—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.00286	CcSEcCtD
Pimozide—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000298	0.00286	CcSEcCtD
Pimozide—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000297	0.00285	CcSEcCtD
Pimozide—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000296	0.00284	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000296	0.00284	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000296	0.00284	CcSEcCtD
Pimozide—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.0028	CcSEcCtD
Pimozide—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000292	0.0028	CcSEcCtD
Pimozide—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000291	0.00279	CcSEcCtD
Pimozide—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000291	0.00279	CcSEcCtD
Pimozide—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00029	0.00278	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00029	0.00278	CcSEcCtD
Pimozide—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000285	0.00273	CcSEcCtD
Pimozide—HTR2A—trachea—chronic obstructive pulmonary disease	0.000283	0.0119	CbGeAlD
Pimozide—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.0027	CcSEcCtD
Pimozide—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.0027	CcSEcCtD
Pimozide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000281	0.00269	CcSEcCtD
Pimozide—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00028	0.00268	CcSEcCtD
Pimozide—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00028	0.00268	CcSEcCtD
Pimozide—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000278	0.00267	CcSEcCtD
Pimozide—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000278	0.00267	CcSEcCtD
Pimozide—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000277	0.00266	CcSEcCtD
Pimozide—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000277	0.00266	CcSEcCtD
Pimozide—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000275	0.00264	CcSEcCtD
Pimozide—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000274	0.00263	CcSEcCtD
Pimozide—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000274	0.00263	CcSEcCtD
Pimozide—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000271	0.0026	CcSEcCtD
Pimozide—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000267	0.00256	CcSEcCtD
Pimozide—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000267	0.00256	CcSEcCtD
Pimozide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000265	0.00254	CcSEcCtD
Pimozide—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000265	0.00254	CcSEcCtD
Pimozide—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000264	0.00253	CcSEcCtD
Pimozide—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000263	0.00252	CcSEcCtD
Pimozide—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000262	0.00251	CcSEcCtD
Pimozide—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.0025	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00026	0.00249	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00026	0.00249	CcSEcCtD
Pimozide—CYP1A2—lung—chronic obstructive pulmonary disease	0.00026	0.0109	CbGeAlD
Pimozide—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000258	0.00248	CcSEcCtD
Pimozide—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000258	0.00248	CcSEcCtD
Pimozide—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.00246	CcSEcCtD
Pimozide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000257	0.00246	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000255	0.00244	CcSEcCtD
Pimozide—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000254	0.00243	CcSEcCtD
Pimozide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000254	0.00243	CcSEcCtD
Pimozide—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000253	0.00242	CcSEcCtD
Pimozide—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000252	0.00241	CcSEcCtD
Pimozide—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000251	0.0105	CbGeAlD
Pimozide—CYP3A5—lung—chronic obstructive pulmonary disease	0.000251	0.0105	CbGeAlD
Pimozide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00025	0.0024	CcSEcCtD
Pimozide—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000248	0.00238	CcSEcCtD
Pimozide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000248	0.00238	CcSEcCtD
Pimozide—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000247	0.00237	CcSEcCtD
Pimozide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000246	0.00236	CcSEcCtD
Pimozide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000246	0.00236	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000245	0.00235	CcSEcCtD
Pimozide—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000244	0.00234	CcSEcCtD
Pimozide—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000244	0.00234	CcSEcCtD
Pimozide—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.00234	CcSEcCtD
Pimozide—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000243	0.00233	CcSEcCtD
Pimozide—HRH1—lung—chronic obstructive pulmonary disease	0.000243	0.0102	CbGeAlD
Pimozide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000241	0.00231	CcSEcCtD
Pimozide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00024	0.0023	CcSEcCtD
Pimozide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000238	0.00229	CcSEcCtD
Pimozide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000236	0.00227	CcSEcCtD
Pimozide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000236	0.00227	CcSEcCtD
Pimozide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000235	0.00225	CcSEcCtD
Pimozide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00225	CcSEcCtD
Pimozide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000234	0.00224	CcSEcCtD
Pimozide—CYP2E1—lung—chronic obstructive pulmonary disease	0.000234	0.00982	CbGeAlD
Pimozide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000233	0.00223	CcSEcCtD
Pimozide—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.00221	CcSEcCtD
Pimozide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000227	0.00217	CcSEcCtD
Pimozide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000227	0.00217	CcSEcCtD
Pimozide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000225	0.00216	CcSEcCtD
Pimozide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000223	0.00214	CcSEcCtD
Pimozide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000223	0.00214	CcSEcCtD
Pimozide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000223	0.00214	CcSEcCtD
Pimozide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000222	0.00213	CcSEcCtD
Pimozide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000221	0.00212	CcSEcCtD
Pimozide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.00205	CcSEcCtD
Pimozide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00021	0.00201	CcSEcCtD
Pimozide—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.00021	0.00201	CcSEcCtD
Pimozide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000205	0.00196	CcSEcCtD
Pimozide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.00196	CcSEcCtD
Pimozide—HTR2A—lung—chronic obstructive pulmonary disease	0.000203	0.00853	CbGeAlD
Pimozide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000202	0.00194	CcSEcCtD
Pimozide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000202	0.00194	CcSEcCtD
Pimozide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000201	0.00192	CcSEcCtD
Pimozide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000198	0.0019	CcSEcCtD
Pimozide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000195	0.00187	CcSEcCtD
Pimozide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000195	0.00187	CcSEcCtD
Pimozide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.00185	CcSEcCtD
Pimozide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000191	0.00183	CcSEcCtD
Pimozide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.00183	CcSEcCtD
Pimozide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000189	0.00181	CcSEcCtD
Pimozide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000189	0.00181	CcSEcCtD
Pimozide—ABCB1—trachea—chronic obstructive pulmonary disease	0.000185	0.00778	CbGeAlD
Pimozide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000185	0.00177	CcSEcCtD
Pimozide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.00177	CcSEcCtD
Pimozide—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000182	0.00174	CcSEcCtD
Pimozide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000181	0.00174	CcSEcCtD
Pimozide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000181	0.00174	CcSEcCtD
Pimozide—Rash—Formoterol—chronic obstructive pulmonary disease	0.00018	0.00173	CcSEcCtD
Pimozide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00018	0.00173	CcSEcCtD
Pimozide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00018	0.00172	CcSEcCtD
Pimozide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00018	0.00172	CcSEcCtD
Pimozide—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.00018	0.00172	CcSEcCtD
Pimozide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.00171	CcSEcCtD
Pimozide—Headache—Formoterol—chronic obstructive pulmonary disease	0.000179	0.00171	CcSEcCtD
Pimozide—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000179	0.00171	CcSEcCtD
Pimozide—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000178	0.00171	CcSEcCtD
Pimozide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000178	0.00171	CcSEcCtD
Pimozide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000178	0.0017	CcSEcCtD
Pimozide—Rash—Montelukast—chronic obstructive pulmonary disease	0.000176	0.00169	CcSEcCtD
Pimozide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000176	0.00169	CcSEcCtD
Pimozide—Depression—Prednisone—chronic obstructive pulmonary disease	0.000176	0.00168	CcSEcCtD
Pimozide—Headache—Montelukast—chronic obstructive pulmonary disease	0.000175	0.00168	CcSEcCtD
Pimozide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.00164	CcSEcCtD
Pimozide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.00163	CcSEcCtD
Pimozide—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00017	0.00163	CcSEcCtD
Pimozide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.00163	CcSEcCtD
Pimozide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000169	0.00163	CcSEcCtD
Pimozide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000169	0.00163	CcSEcCtD
Pimozide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.00162	CcSEcCtD
Pimozide—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.0016	CcSEcCtD
Pimozide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000166	0.00159	CcSEcCtD
Pimozide—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000164	0.00157	CcSEcCtD
Pimozide—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.00157	CcSEcCtD
Pimozide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.00154	CcSEcCtD
Pimozide—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00149	CcSEcCtD
Pimozide—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000152	0.00146	CcSEcCtD
Pimozide—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.00145	CcSEcCtD
Pimozide—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.00143	CcSEcCtD
Pimozide—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000148	0.00142	CcSEcCtD
Pimozide—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00014	0.00134	CcSEcCtD
Pimozide—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000138	0.00133	CcSEcCtD
Pimozide—ABCB1—lung—chronic obstructive pulmonary disease	0.000133	0.00559	CbGeAlD
Pimozide—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00013	0.00124	CcSEcCtD
Pimozide—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00122	CcSEcCtD
Pimozide—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000126	0.00121	CcSEcCtD
Pimozide—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000123	0.00118	CcSEcCtD
Pimozide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.00118	CcSEcCtD
Pimozide—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000121	0.00116	CcSEcCtD
Pimozide—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000119	0.00114	CcSEcCtD
Pimozide—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000119	0.00114	CcSEcCtD
Pimozide—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000117	0.00112	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00112	CcSEcCtD
Pimozide—Shock—Prednisone—chronic obstructive pulmonary disease	0.00011	0.00106	CcSEcCtD
Pimozide—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.00011	0.00106	CcSEcCtD
Pimozide—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.00011	0.00105	CcSEcCtD
Pimozide—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000109	0.00105	CcSEcCtD
Pimozide—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000109	0.00104	CcSEcCtD
Pimozide—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000107	0.00103	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000981	CcSEcCtD
Pimozide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.00098	CcSEcCtD
Pimozide—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000974	CcSEcCtD
Pimozide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	9.76e-05	0.000936	CcSEcCtD
Pimozide—Rash—Prednisolone—chronic obstructive pulmonary disease	9.74e-05	0.000935	CcSEcCtD
Pimozide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	9.73e-05	0.000934	CcSEcCtD
Pimozide—Headache—Prednisolone—chronic obstructive pulmonary disease	9.68e-05	0.000929	CcSEcCtD
Pimozide—Constipation—Prednisone—chronic obstructive pulmonary disease	9.6e-05	0.000921	CcSEcCtD
Pimozide—Nausea—Prednisolone—chronic obstructive pulmonary disease	9.18e-05	0.00088	CcSEcCtD
Pimozide—Urticaria—Prednisone—chronic obstructive pulmonary disease	8.92e-05	0.000856	CcSEcCtD
Pimozide—Asthenia—Prednisone—chronic obstructive pulmonary disease	8.06e-05	0.000773	CcSEcCtD
Pimozide—Pruritus—Prednisone—chronic obstructive pulmonary disease	7.94e-05	0.000762	CcSEcCtD
Pimozide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	7.68e-05	0.000737	CcSEcCtD
Pimozide—Dizziness—Prednisone—chronic obstructive pulmonary disease	7.43e-05	0.000712	CcSEcCtD
Pimozide—Vomiting—Prednisone—chronic obstructive pulmonary disease	7.14e-05	0.000685	CcSEcCtD
Pimozide—Rash—Prednisone—chronic obstructive pulmonary disease	7.08e-05	0.000679	CcSEcCtD
Pimozide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	7.07e-05	0.000679	CcSEcCtD
Pimozide—Headache—Prednisone—chronic obstructive pulmonary disease	7.03e-05	0.000675	CcSEcCtD
Pimozide—Nausea—Prednisone—chronic obstructive pulmonary disease	6.67e-05	0.00064	CcSEcCtD
Pimozide—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.93e-06	7.88e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.92e-06	7.87e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.88e-06	7.82e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	6.86e-06	7.8e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.81e-06	7.75e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.81e-06	7.74e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.8e-06	7.73e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.77e-06	7.7e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.76e-06	7.68e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.7e-06	7.62e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.7e-06	7.62e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.69e-06	7.61e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.69e-06	7.61e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—NOS2—chronic obstructive pulmonary disease	6.69e-06	7.61e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.69e-06	7.61e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.68e-06	7.6e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.65e-06	7.56e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.62e-06	7.53e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.62e-06	7.52e-05	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	6.54e-06	7.44e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.5e-06	7.39e-05	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—EGFR—chronic obstructive pulmonary disease	6.49e-06	7.38e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—NOS2—chronic obstructive pulmonary disease	6.47e-06	7.36e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—NOS2—chronic obstructive pulmonary disease	6.47e-06	7.36e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.4e-06	7.28e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.4e-06	7.28e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.39e-06	7.26e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.37e-06	7.25e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.31e-06	7.18e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.3e-06	7.16e-05	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—EGFR—chronic obstructive pulmonary disease	6.27e-06	7.14e-05	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—EGFR—chronic obstructive pulmonary disease	6.27e-06	7.14e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	6.26e-06	7.12e-05	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	6.26e-06	7.12e-05	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	6.23e-06	7.08e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.18e-06	7.03e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.18e-06	7.02e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.16e-06	7e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.09e-06	6.93e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.09e-06	6.92e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.07e-06	6.91e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.06e-06	6.89e-05	CbGpPWpGaD
Pimozide—CALM3—Hemostasis—TP53—chronic obstructive pulmonary disease	6.05e-06	6.88e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.04e-06	6.87e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.03e-06	6.85e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.03e-06	6.85e-05	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	6.03e-06	6.85e-05	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	6.03e-06	6.85e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.99e-06	6.81e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.98e-06	6.8e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.98e-06	6.8e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.95e-06	6.76e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.95e-06	6.76e-05	CbGpPWpGaD
Pimozide—CALM1—Hemostasis—TP53—chronic obstructive pulmonary disease	5.85e-06	6.65e-05	CbGpPWpGaD
Pimozide—CALM2—Hemostasis—TP53—chronic obstructive pulmonary disease	5.85e-06	6.65e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.78e-06	6.57e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.77e-06	6.56e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.69e-06	6.47e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.68e-06	6.46e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.68e-06	6.45e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.66e-06	6.43e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—SERPINE1—chronic obstructive pulmonary disease	5.64e-06	6.41e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.62e-06	6.39e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.6e-06	6.37e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.54e-06	6.3e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.5e-06	6.26e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.47e-06	6.22e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.47e-06	6.22e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—SERPINE1—chronic obstructive pulmonary disease	5.45e-06	6.2e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—SERPINE1—chronic obstructive pulmonary disease	5.45e-06	6.2e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.44e-06	6.18e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.44e-06	6.18e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.41e-06	6.15e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.4e-06	6.14e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.38e-06	6.12e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—NOS3—chronic obstructive pulmonary disease	5.38e-06	6.12e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.36e-06	6.09e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.35e-06	6.08e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	5.3e-06	6.02e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.25e-06	5.97e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.25e-06	5.97e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.23e-06	5.95e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.23e-06	5.95e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.22e-06	5.94e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—NOS3—chronic obstructive pulmonary disease	5.2e-06	5.92e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—NOS3—chronic obstructive pulmonary disease	5.2e-06	5.92e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.19e-06	5.9e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.13e-06	5.84e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.11e-06	5.81e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.08e-06	5.78e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.06e-06	5.76e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.03e-06	5.72e-05	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—IL6—chronic obstructive pulmonary disease	4.99e-06	5.67e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.98e-06	5.66e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.97e-06	5.65e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL1B—chronic obstructive pulmonary disease	4.96e-06	5.64e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.95e-06	5.63e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.89e-06	5.56e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.88e-06	5.55e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.86e-06	5.53e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.86e-06	5.53e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.84e-06	5.5e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	4.83e-06	5.5e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.83e-06	5.49e-05	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—IL6—chronic obstructive pulmonary disease	4.82e-06	5.48e-05	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—IL6—chronic obstructive pulmonary disease	4.82e-06	5.48e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.81e-06	5.47e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL1B—chronic obstructive pulmonary disease	4.8e-06	5.45e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL1B—chronic obstructive pulmonary disease	4.8e-06	5.45e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.76e-06	5.41e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.75e-06	5.41e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.75e-06	5.4e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.74e-06	5.39e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	4.74e-06	5.39e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	4.73e-06	5.38e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—ALB—chronic obstructive pulmonary disease	4.71e-06	5.36e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.69e-06	5.34e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.67e-06	5.31e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.67e-06	5.31e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.66e-06	5.3e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.61e-06	5.25e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.6e-06	5.23e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—ALB—chronic obstructive pulmonary disease	4.56e-06	5.18e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—ALB—chronic obstructive pulmonary disease	4.56e-06	5.18e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.54e-06	5.16e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.53e-06	5.16e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.53e-06	5.15e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	4.53e-06	5.15e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—NOS3—chronic obstructive pulmonary disease	4.51e-06	5.12e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.46e-06	5.07e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.45e-06	5.06e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.43e-06	5.04e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.42e-06	5.03e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.38e-06	4.99e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.36e-06	4.96e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.36e-06	4.96e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.34e-06	4.94e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.21e-06	4.79e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.19e-06	4.77e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.13e-06	4.7e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.09e-06	4.65e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.03e-06	4.58e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.02e-06	4.58e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.02e-06	4.57e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4e-06	4.55e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4e-06	4.55e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.99e-06	4.53e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.95e-06	4.49e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.95e-06	4.49e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.95e-06	4.49e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.92e-06	4.46e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.91e-06	4.44e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.89e-06	4.42e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.86e-06	4.39e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.83e-06	4.35e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.82e-06	4.34e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.82e-06	4.34e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.82e-06	4.34e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.78e-06	4.3e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—EGFR—chronic obstructive pulmonary disease	3.78e-06	4.3e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.77e-06	4.28e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.76e-06	4.27e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.71e-06	4.22e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.7e-06	4.21e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.66e-06	4.17e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	3.66e-06	4.16e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—EGFR—chronic obstructive pulmonary disease	3.65e-06	4.16e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—EGFR—chronic obstructive pulmonary disease	3.65e-06	4.16e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.64e-06	4.14e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.64e-06	4.14e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.64e-06	4.14e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.63e-06	4.13e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.59e-06	4.08e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.58e-06	4.07e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	3.57e-06	4.06e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—TGFB1—chronic obstructive pulmonary disease	3.56e-06	4.05e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.54e-06	4.02e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	3.5e-06	3.98e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—EGFR—chronic obstructive pulmonary disease	3.49e-06	3.97e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.47e-06	3.95e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—TGFB1—chronic obstructive pulmonary disease	3.44e-06	3.91e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—TGFB1—chronic obstructive pulmonary disease	3.44e-06	3.91e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.41e-06	3.88e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.41e-06	3.88e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.41e-06	3.87e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—EGFR—chronic obstructive pulmonary disease	3.37e-06	3.84e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—EGFR—chronic obstructive pulmonary disease	3.37e-06	3.84e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	3.36e-06	3.83e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.34e-06	3.8e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.32e-06	3.78e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.31e-06	3.77e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.28e-06	3.73e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.27e-06	3.72e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.26e-06	3.71e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.24e-06	3.68e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.23e-06	3.68e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.23e-06	3.68e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.22e-06	3.66e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.21e-06	3.65e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.18e-06	3.61e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.07e-06	3.5e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.07e-06	3.5e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.05e-06	3.47e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.03e-06	3.45e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.02e-06	3.44e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3e-06	3.42e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3e-06	3.41e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.99e-06	3.41e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.99e-06	3.4e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.95e-06	3.35e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.94e-06	3.35e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.94e-06	3.34e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.92e-06	3.32e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.92e-06	3.32e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL6—chronic obstructive pulmonary disease	2.9e-06	3.3e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.89e-06	3.29e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.86e-06	3.25e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.85e-06	3.24e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL6—chronic obstructive pulmonary disease	2.81e-06	3.19e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL6—chronic obstructive pulmonary disease	2.81e-06	3.19e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.73e-06	3.1e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.71e-06	3.09e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—IL6—chronic obstructive pulmonary disease	2.68e-06	3.05e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.63e-06	2.99e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.63e-06	2.99e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.62e-06	2.98e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—IL6—chronic obstructive pulmonary disease	2.59e-06	2.95e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—IL6—chronic obstructive pulmonary disease	2.59e-06	2.95e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.51e-06	2.86e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.49e-06	2.83e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.47e-06	2.81e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.47e-06	2.8e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.44e-06	2.78e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.43e-06	2.76e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.41e-06	2.74e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.41e-06	2.74e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.36e-06	2.69e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.36e-06	2.69e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.3e-06	2.61e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.26e-06	2.57e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.26e-06	2.57e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.22e-06	2.52e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.2e-06	2.5e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.1e-06	2.39e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.05e-06	2.33e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.98e-06	2.26e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.98e-06	2.26e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.88e-06	2.13e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.82e-06	2.06e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.82e-06	2.06e-05	CbGpPWpGaD
